Physician profile
Robert Fuller
NPI 1932177482
$1,504.23
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $333 · 2021: $70.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $388.08 | 2019-2020 | |
| Abbvie INC. | $321.28 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $176.74 | 2019-2020 | |
| Celgene Corporation | $78.70 | 2019 | |
| Lilly USA, LLC | $77.17 | 2019-2020 | |
| Pfizer INC. | $72.54 | 2019-2020 | |
| Genentech USA, INC. | $64.22 | 2019-2020 | |
| Janssen Biotech, INC. | $50.98 | 2019-2020 | |
| Amgen INC. | $43.29 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $37.78 | 2019 | |
| Leo Pharma INC. | $36.42 | 2019-2021 | |
| Genzyme Corporation | $29.81 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.35 | 2019 | |
| Ucb, INC. | $25.55 | 2020 | |
| Sun Pharmaceutical Industries INC. | $20.53 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $20.48 | 2019 | |
| Smith+Nephew, INC. | $17.89 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $13.42 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.